The Next Generation Sequencing (NGS) market is characterized by intense technological competition, primarily between established short-read sequencing platforms and burgeoning long-read technologies. Short-read sequencing, pioneered by companies like Illumina, dominates the market due to its high accuracy, massive throughput, and cost-effectiveness for applications like whole-genome and exome...